Literature DB >> 30095711

RETINAL-CHOROIDAL ANASTOMOSIS IN MACULAR TELANGIECTASIA TYPE 2.

Richard F Spaide1, Lawrence A Yannuzzi1, Peter M Maloca2.   

Abstract

PURPOSE: To investigate the deep retinal vascular changes potentially present in macular telangiectasis Type 2 (MacTel 2) with projection resolved optical coherence tomography angiography including volume rendering.
METHODS: Retrospective consecutive evaluation of patients with MacTel 2 in a community-based retinal referral practice with a comprehensive ophthalmologic examination to include optical coherence tomography and projection-resolved optical coherence tomography angiography with volume rendering. Main outcome measures were the characterization of vessel presence and anatomical arrangement in the outer retina.
RESULTS: There were 26 eyes of 13 patients with a mean age of 64.9 (±11.3) years, and 6 were men. The mean visual acuity was logMAR 0.4 (Snellen equivalent 20/50). No eye had signs of choroidal neovascularization or exudation. Focal hyperpigmentation was seen in 13 (50%) and right-angle veins in 17 (65%) eyes. Retinal-choroidal anastomoses were seen in 17 (65%) eyes. These anastomoses typically occurred in multiple clusters of small vessels. The presence of anastomoses was associated with pigment (P < 0.001), although the anastomoses did not necessarily colocalize with the pigment, and right-angle veins (P < 0.001), which were found in every eye with a retinal-choroidal anastomosis.
CONCLUSION: Retinal-choroidal anastomoses were commonly observed in eyes with MacTel 2 using projection-resolved optical coherence tomography angiography. One animal model for MacTel 2 uses very low-density lipoprotein receptor mutant mice and shows multiple retinal-choroidal anastomoses in the disease pathogenesis as well. These findings suggest MacTel 2 is more than just a neurodegenerative disease with secondary vascular abnormalities, as the choroid may be involved in the disease process.

Entities:  

Mesh:

Year:  2018        PMID: 30095711     DOI: 10.1097/IAE.0000000000002289

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  6 in total

Review 1.  Imaging endpoints for clinical trials in MacTel type 2.

Authors:  Daniel Pauleikhoff; Laurenz Pauleikhoff; Emily Y Chew
Journal:  Eye (Lond)       Date:  2021-08-13       Impact factor: 3.775

2.  Multimodal imaging of macular telangiectasia type 2 in a pediatric patient.

Authors:  Magdy Moussa; Mahmoud Leila; Omar Moussa
Journal:  Am J Ophthalmol Case Rep       Date:  2021-04-01

3.  Does size of telangiectasia on optical coherence tomography angiography influence vision in eyes with type 2 macular telangiectasia?

Authors:  Aditya S Kelkar; Jai A Kelkar; Sayali Tidke; Aanchal Agarwal; Mounika Bolisetty; Shreekant Kelkar
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

4.  Reference database of total retinal vessel surface area derived from volume-rendered optical coherence tomography angiography.

Authors:  Peter M Maloca; Silvia Feu-Basilio; Julia Schottenhamml; Philippe Valmaggia; Hendrik P N Scholl; Josep Rosinés-Fonoll; Sara Marin-Martinez; Nadja Inglin; Michael Reich; Clemens Lange; Catherine Egan; Sandrine Zweifel; Adnan Tufail; Richard F Spaide; Javier Zarranz-Ventura
Journal:  Sci Rep       Date:  2022-03-07       Impact factor: 4.379

5.  Clinical Features of Untreated Type 2 Macular Telangiectasia and Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Macular Neovascularization

Authors:  Müge Çoban Karataş; Gürsel Yılmaz; Aslıhan Yüce Sezen; Çağla Sarıtürk
Journal:  Turk J Ophthalmol       Date:  2022-02-23

6.  Choroidal vascularity index change in macular telangiectasia type 2.

Authors:  Heejeong Chun; Hyun Suh; Joo Young Kim; Jae Hyuck Kwak; Rae Young Kim; Mirinae Kim; Young-Gun Park; Young-Hoon Park
Journal:  PLoS One       Date:  2022-04-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.